ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

Solution: Federal And State Policy

In The News Lindsay Bealor Greenleaf Interviewed by Pharmacy Times on IRA Drug Pricing Announcement
In The News Lindsay Bealor Greenleaf Discusses IRA Negotiated Drug Prices with Managed Healthcare Executive
In The News Lindsay Bealor Greenleaf Shares IRA Insights In Axios

Insights,

Aug 13 2024 | Lindsay Bealor Greenleaf, JD, MBA - Head of Policy, Research, and Analysis

ADVI Instant: CMS Releases Final Part Two Guidance for the MPPP Program

Insights,

Aug 13 2024 | Lindsay Bealor Greenleaf, JD, MBA - Head of Policy, Research, and Analysis

ADVI Instant: CMS Releases the FY 2025 IPPS Final Rule

Case Study: Strengthening Positioning for IRA Drug Price Negotiation

In The News Lindsay Bealor Greenleaf Speaks with Politico on Possible Vice President Harris Nomination in the 2024 Presidential Election
In The News Lindsay Bealor Greenleaf Speaks with Politico on Shifts in the 2024 Presidential Election
In The News ADVI Expert Lindsay Bealor Greenleaf Featured in Pink Sheet

Posts pagination

< Previous page 1 … 5 6 7 … 22 Next page >
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health